These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25042583)

  • 1. In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.
    Liu W; Nair G; Vuolo L; Bakshi A; Massoud R; Reich DS; Jacobson S
    Ann Neurol; 2014 Sep; 76(3):370-8. PubMed ID: 25042583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.
    Evangelou IE; Massoud R; Jacobson S
    J Neuroimaging; 2014; 24(1):74-8. PubMed ID: 22303896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
    Menezes SM; Decanine D; Brassat D; Khouri R; Schnitman SV; Kruschewsky R; López G; Alvarez C; Talledo M; Gotuzzo E; Vandamme AM; Galvão-Castro B; Liblau R; Weyenbergh JV
    J Neuroinflammation; 2014 Jan; 11():18. PubMed ID: 24472094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.
    Morgan DJ; Caskey MF; Abbehusen C; Oliveira-Filho J; Araujo C; Porto AF; Santos SB; Orge GO; Joia MJ; Muniz AL; Siqueira I; Glesby MJ; Carvalho E
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1499-504. PubMed ID: 18160007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain and spinal cord magnetic resonance imaging in spastic paraparesis associated to human T-lymphotropic virus].
    Cervilla J; Cartier L; García L
    Rev Med Chil; 2006 Aug; 134(8):1010-8. PubMed ID: 17130989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Vilchez C; Gonzalez-Reinoso M; Cubbison C; Perez-Then E; Roa P; Martínez A; Foerster B; Oviedo J; Stoeter P
    J Neurovirol; 2014 Dec; 20(6):583-90. PubMed ID: 25227931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurological symptoms and disability in HTLV-1 associated myelopathy].
    Carod-Artal FJ; Mesquita HM; Ribeiro Lda S
    Neurologia; 2008 Mar; 23(2):78-84. PubMed ID: 18322825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord anteroposterior atrophy in HAM/TSP: Magnetic resonance imaging and neuropathological analyses.
    Taniguchi A; Mochizuki H; Yamashita A; Shiomi K; Asada Y; Nakazato M
    J Neurol Sci; 2017 Oct; 381():135-140. PubMed ID: 28991665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
    Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
    J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.
    Kira J; Fujihara K; Itoyama Y; Goto I; Hasuo K
    J Neurol Sci; 1991 Nov; 106(1):41-9. PubMed ID: 1779238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives.
    Howard AK; Li DK; Oger J
    Can J Neurol Sci; 2003 Feb; 30(1):41-8. PubMed ID: 12619783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Nakamura T; Nishiura Y; Eguchi K
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
    Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAM/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings.
    Puccioni-Sohler M; Gasparetto E; Cabral-Castro MJ; Slatter C; Vidal CM; Cortes RD; Rosen BR; Mainero C
    Arq Neuropsiquiatr; 2012 Apr; 70(4):246-51. PubMed ID: 22510735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.